Biodistribution of ¹³¹I-30F11 (antimurine CD45) in a syngeneic murine T-NHL model. (A) Percentage injected ¹³¹I dose/g tissue (%ID/g) in target (■) and nontarget (▨) organs after ¹³¹I-30F11 (antimurine CD45) in an EL-4 (murine T-NHL) model. (B) The resultant tumor-to-normal organ ratios (24 hours).